| Date Filed | Type | Description |
| 10/05/2023 |
4
| SHAH JAISIM (See Remarks) has filed a Form 4 on Scilex Holding Co|
Txns:
| Granted 200,000 options to buy
@ $1.41, valued at
$282k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
3
| SHAH JAISIM (See Remarks) has filed a Form 3 on Vickers Vantage Corp. I |
| 08/30/2021 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 06/15/2020 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $4.89, valued at
$489k
|
|
| 04/23/2019 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 70,000 options
@ $3.78, valued at
$264.6k
|
|
| 11/27/2018 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 35,000 options
@ $3.57, valued at
$125k
|
|
| 09/18/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 10,002 shares
@ $1.79, valued at
$17.9k
|
|
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/12/2016 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc. |
| 08/05/2015 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 27,189 shares
@ $11.5, valued at
$312.7k
|
|
| 06/08/2015 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $13.79, valued at
$344.8k
|
|
| 02/26/2015 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 80,000 options
@ $12.78, valued at
$1M
|
|
| 09/22/2014 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $4.78, valued at
$119.5k
|
|
| 11/26/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/20/2013 |
4
| SHAH JAISIM (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $9, valued at
$9k
|
|
| 10/31/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2009 |
3
| SHAH JAISIM (Sr. VP - Business Development) has filed a Form 3 on CYTRX CORP |
| 12/22/2008 |
3
| SHAH JAISIM (SVP, Chief Business Officer) has filed a Form 3 on FACET BIOTECH CORP |